Thomas C Hermann

Anadys Pharmaceuticals, Inc.

$4,635,668

Attributed

$4,635,668

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $693.4K · FY2005–22

$1M$750K$500K$250K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$4,635,668 · 7

By mechanism

R01$3,400,829 · 2

R44$536,400 · 1

R21$426,441 · 1

R43$225,000 · 1

R13$31,875 · 1

P41$15,123 · 1

Top collaborators

No co-investigators on record.

Most similar at Anadys Pharmaceuticals, Inc.

Same institution · by research overlap

Daniel Wall$5,069,217

Others in their field

Top investigators on “Ligands”

John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
Keith W Miller · Massachusetts General Hospital$35,506,092
Ian A Wilson · Scripps Research Institute, The$35,392,112
Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
Helen M Berman · Rutgers University New Brunswick$32,076,400

Research focus

LigandsStructureTranslationsGenomeBaseDesignSmall MoleculeIn VitroLigand BindingLeadPharmaceutical PreparationsAffinityInhibitor/AntagonistBiologicalCrystallizationElementsThree Dimensional StructureIndiumBiological FactorsFunctional GroupBinding (Molecular Function)OligonucleotidesPreventBiochemical